Publications en collaboration avec des chercheurs de Hospital Universitario de Donostia (22)

2024

  1. Profile of Patients With Moderate-to-Severe Atopic Dermatitis and Chronic Urticaria Undergoing Biological Treatment in Hospital Allergy Units in Spain: First Report of the Alergodata Registry

    Journal of investigational allergology & clinical immunology, Vol. 34, Núm. 2, pp. 131-133

2023

  1. Use of Concentrated Plasma-Derived Subcutaneous C1 Inhibitor as Long-Term Prophylaxis in an 8-Year-Old Child With Hereditary Angioedema

    Journal of Investigational Allergology and Clinical Immunology

2022

  1. Effect of the SARS-CoV-2 pandemic on the control and severity of pediatric asthma

    Allergologia et Immunopathologia, Vol. 50, Núm. 1, pp. 99-103

  2. Onset of Nut Allergy in a Pediatric Cohort: Clinical and Molecular Patterns in the AFRUSEN Study

    Journal of investigational allergology & clinical immunology, Vol. 32, Núm. 4, pp. 270-281

  3. The Quantification of IgG Specific to α-Gal Could Be Used as a Risk Marker for Suffering Mammalian Meat Allergy

    Foods, Vol. 11, Núm. 3

2021

  1. Oral immunotherapy in severe cow’s milk allergic patients treated with omalizumab: Real life survey from a Spanish registry

    Pediatric Allergy and Immunology, Vol. 32, Núm. 6, pp. 1287-1295

2019

  1. Contact urticaria caused by phenoxyethanol in ultrasound gel

    Contact Dermatitis, Vol. 81, Núm. 2, pp. 132-133

  2. Recommendations for the use of propofol in egg-allergic patients

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 1, pp. 72-74

2018

  1. Prospective assessment of diagnostic tests for pediatric penicillin allergy: From clinical history to challenge tests

    Annals of Allergy, Asthma and Immunology, Vol. 121, Núm. 2, pp. 235-244.e3

2017

  1. Anaphylaxis caused by immediate hypersensitivity to topical chlorhexidine in children

    Annals of Allergy, Asthma and Immunology, Vol. 118, Núm. 1, pp. 118-119

  2. Heterogeneity in allergy to mollusks: A clinical-immunological study in a population from the north of Spain

    Journal of Investigational Allergology and Clinical Immunology, Vol. 27, Núm. 4, pp. 252-260

2016

  1. Lipid transfer protein syndrome in a non-mediterranean area

    International Archives of Allergy and Immunology, Vol. 169, Núm. 3, pp. 181-188

2015

  1. Epidemiology of asthma exacerbations and their relation with environmental factors in the Basque Country

    Clinical and Experimental Allergy, Vol. 45, Núm. 6, pp. 1099-1108

  2. Vespa velutina nigritorax: A new causative agent in anaphylaxis

    Journal of Investigational Allergology and Clinical Immunology, Vol. 25, Núm. 3, pp. 231-232

2014

  1. Diagnosis and allergen immunotherapy treatment of polysensitised patients with respiratory allergy in Spain: An Allergists' Consensus

    Clinical and Translational Allergy, Vol. 4, Núm. 1

2013

  1. In vivo and in vitro techniques in the diagnosis of lipid transfer protein sensitization

    Annals of Allergy, Asthma and Immunology, Vol. 111, Núm. 6, pp. 571-573

  2. Managing paediatric anaphylaxis

    US Respiratory Disease, Vol. 8, Núm. 2, pp. 101-107

2012

  1. Managing Paediatric anaphylaxis

    European Respiratory Disease, Vol. 8, Núm. 2, pp. 101-107

  2. Managing pediatric anaphylaxis

    US Respiratory Disease, Vol. 8, Núm. 1, pp. 23-29

2011

  1. Assessment of short-term changes induced by a Dermatophagoides pteronyssinus extract on asthmatic patients. Randomised, double-blind, placebo-controlled trial

    Current Drug Delivery, Vol. 8, Núm. 2, pp. 152-158